Ausun Pharm(SH:603229) Zheng Quan Zhi Xing·2025-07-09 09:15Core Viewpoint - The company has announced an adjustment to the maximum repurchase price of its shares following the implementation of its 2024 annual profit distribution plan, reducing the price from RMB 14 to RMB 13.90 per share [1][2][4] Summary by Sections 1. Share Repurchase Basic Information - The company plans to repurchase its shares using its own and/or raised funds through centralized bidding, with a total repurchase amount between RMB 50 million and RMB 100 million [1] - The repurchase price was initially set at a maximum of RMB 14 per share, with a repurchase period of 12 months starting from the board's approval date [1] 2. Reasons for Adjusting the Repurchase Price Cap - The adjustment follows the approval of the 2024 annual profit distribution plan, which includes a cash dividend of RMB 0.10 per share, totaling RMB 82,829,774.50 [2][3] - The record date for the dividend distribution is July 16, 2025, and the ex-dividend date is July 17, 2025 [2] 3. Details of the Price Adjustment - The new maximum repurchase price is calculated as follows: (previous maximum price - cash dividend) / (1 + change in circulating shares ratio) [2] - The cash dividend per share is approximately RMB 0.0998, and since there is no change in circulating shares, the new maximum repurchase price is approximately RMB 13.90 [3] 4. Other Matters - Other aspects of the share repurchase plan remain unchanged, and the company will proceed with the repurchase plan in accordance with relevant laws and regulations [4]